Bispecific antibodies direct the immune system against blood cancers Researchers at US biotech company Genentech have developed a bispecific antibody that they say is “highly active” against leukaemia and lymphoma cells.…
Structure of translocator protein hints at role in disease Two research groups have independently solved the structures of similar translocator proteins, offering clues about its function that could spur the development of targeted drugs.…
Bacteria’s protein machinery may offer antibiotic target Researchers have unveiled a snapshot of the molecular machinery that bacteria use to build polysaccharide chains that protect them from immune attack.…
Stratified medicine is changing our concept of disease Understanding the different molecular pathways behind a disease will help doctors to manage it.…
Sequencing cancer genomes to tailor treatments to individual patients Screening for hundreds of mutations in tumours is the most promising route to customised drug treatments for cancer.…
Genes influence response to statins, research finds Four genes are responsible for about 5% of the variation in an individual’s response to statin treatment, research suggests.…
